findmyKOL
Clinical trialNCT06263452RecruitingPhase 4Interventional

Beta-Blocker Influences on Inflammatory and Neural Responses to Stress

SponsorUniversity of North Carolina, Chapel HillEnrollment120Cardiovascular Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to map the neural and molecular mechanisms underlying psychological stress-induced changes in inflammation which could reveal new targets for intervention to reduce the risk of cardiovascular disease.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Social Neuroscience and Health Laboratory

    Chapel Hill, North Carolina, United States

    Jessica R Cohen, PhDKristen A Lindquist, PhDZev Nakamura, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 May 2024
Primary completion
31 May 2026
Completion
31 May 2026
Last update posted
29 Oct 2025
Registered enrollment
120
Registry id
NCT06263452

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.